IVY HOO: Open Payments
NPI 1164136529 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,376 in 84 payments from 14 companies in 2025. Trend: 2023 $2,270 · 2024 $3,423 · 2025 $2,376
Food & beverage: $2,376
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 23 | $395 |
| E.R. Squibb & Sons, L.L.C. | 10 | $382 |
| Axsome Therapeutics, Inc. | 10 | $381 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $325 |
| ABBVIE INC. | 18 | $305 |
| Teva Pharmaceuticals USA, Inc. | 3 | $142 |
| Otsuka America Pharmaceutical, Inc. | 2 | $137 |
| Tris Pharma Inc | 2 | $120 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Vertical Pharmaceuticals, LLC | 2 | $38 |
Products named: REXULTI, COBENFY, Auvelity, CAPLYTA, VRAYLAR, UZEDY, Dyanavel XR, Jornay PM.
Industry payments across CO — which companies pay providers there.
